In the News
New York Post: This Texas county has one of the highest dementia rates in the US — what’s behind it?
By Diana Bruk Published May 1, 2025, 3:10 p.m. A county in southern Texas, near the US-Mexico border, is suffering from a bit of an epidemic. Starr County has emerged as a national hot spot — not for tourism or industry, but for having one of the highest rates of dementia in the country. Roughly one in five seniors […]
Daily Mail EXCLUSIVE: Unassuming US town being gripped by DEMENTIA epidemic: ‘Everybody’s got it’
Published: 01:45 EDT, 1 May 2025 | Updated: 08:26 EDT, 1 May 2025 While it might appear like just another sleepy border town, Rio Grande City in southern Texas has a dark secret. The community of just over 15,000 residents has one of the highest dementia rates in America. One in four people here over the age of 65 have it compared to around […]
Pastor recognized for her volunteerism in Alzheimer’s research
BY SETH VOORHEES OSWEGO | spectrumlocalnews OWEGO, N.Y. — Nearly seven million Americans live with Alzheimer’s disease, and according to the National Institutes of Health, the number could grow by 50% by 2060. It’s a stunning number, but researchers say they’re making great progress in understanding and preventing the disease, which affects memory, thinking and behavior. An author and […]
PR Newswire: iLoF and Industry Leader Hamamatsu Announce Strategic Investment in a Collaboration to Advance the Future of Personalized Medicine
iLoF, the leading innovator in AI-powered photonics platforms for personalised medicine, announces today a strategic investment from Hamamatsu, the world expert in the development and manufacturing of photonics devices and systems for medical optics and biophotonics, to further its mission of transforming healthcare and driving innovation in medicine. LONDON, Oct. 22, 2024 /PRNewswire/ — iLoF, the leading company […]
Encuentros Interactivos: Dilenia Cruz recibe el reconocimiento Citizen Scientist Cultivator Honoree 2024 por su labor en salud cerebral
*”This story reposted in its entirely in the original posted language”*En un evento celebrado en la Conferencia de Optimización de Sitios GAP-Net 2025 en Miami, Florida, la Global Alzheimer’s Platform Foundation® reconoció a Dilenia Cruz como una de las figuras clave en la lucha contra enfermedades neurodegenerativas al otorgarle el prestigioso título de Citizen Scientist Cultivator […]
NBC 4: Arlington woman shares young-onset Parkinson’s journey and advocates for research
Allison “Allie” Signorelli started sharing her journey with young-onset Parkinson’s on Instagram to create a community with others. Since then, she has joined research studies and teamed up with advocates to spread awareness. News4’s Molette Green reports. View segment here: https://www.nbcwashington.com/community/in-the-community/arlington-woman-shares-young-onset-parkinsons-journey-and-advocates-for-research/3876476
The Pathologist: No Alzheimer’s Patient Left Behind
A blood-based diagnostic test for neurodegenerative diseases is a global priority By Zivjena Vucetic 03/21/2025 As the global population ages, the incidence of neurodegenerative diseases such as Alzheimer’s disease (AD) is rapidly increasing. By 2050, the global population of people over the age of 60 is expected to double, reaching 2.1 billion individuals, while those over 80 […]
Elk Grove hospital hosts trials on potential new Alzheimer’s treatments
By Christopher Placek – Daily Herald More than a decade after hosting clinical trials for two medications now commonly used to slow the progression of Alzheimer’s disease, researchers at Ascension Alexian Brothers hospital in Elk Grove Village are now studying potential new treatments to address the neurological disorder. “We have these two very interesting studies […]
Alliance for Aging Research: Alliance, Partnership to Fight Chronic Disease, and the Global Alzheimer’s Platform Foundation Comment on Accelerated Approval Guidances
By Aging Research, Published March 10, 2025 Aging Research The Alliance for Aging Research, the Partnership to Fight Chronic Disease (PFCD), and the Global Alzheimer’s Platform Foundation (GAP) submitted comments today on both of the recently issued draft guidances on accelerated approval—Expedited Programs for Serious Conditions—Accelerated Approval of Drugs and Biologics (hereafter the “Programmatic Guidance”) and Accelerated Approval and Considerations for […]
The Examiner: ‘I don’t have the same frustrations’: Alzheimer’s patient awarded for participation in medical trial
John Peters said the clinical trial he participated in at the Kawartha Centre gave him parts of his life back. John Peters wasn’t surprised when he started having trouble remembering things — he knew both his father and grandfather battled with Alzheimer’s. “The only big difference was I never smoked,” said Peters. “I was not […]